EXPLORE THE SCIENCE
TL;DR: In mice, a new type of gene-silencing molecule lowered levels of alpha-synuclein, the protein that clumps in Parkinson’s. Mice given it kept more dopamine-making brain cells and did better on grip and balance tests than untreated mice with the same dise…
Read article
TL;DR: A 2026 study in Nature Communications reported that tubulin redirected Tau and alpha-synuclein condensates toward microtubule-building states, while tubulin loss pushed the same protein system toward toxic oligomers in cell models. Key Findings 36-hour…
Read article
TL;DR: A 2026 medRxiv preprint reported that peripheral blood RNA sequencing separated Parkinson disease from healthy controls and isolated REM sleep behavior disorder more clearly than it separated isolated REM sleep behavior disorder from controls. Key Findi…
Read article
TL;DR: A 2026 review in Translational Neurodegeneration found that most repurposed multiple system atrophy drugs failed to show disease-slowing effects in trials, while ubiquinol produced the clearest placebo-controlled motor-progression signal. Key Findings N…
Read article
TL;DR: A 2026 study in Genes & Diseases found that Il6 deficiency, meaning loss of the gene for interleukin-6, worsened Parkinson’s-like motor and dopamine-system injury in mice. Key Findings Il6 knockout worsened movement: Mice lacking Il6 performed worse aft…
Read article
TL;DR: A 2026 study in Molecular Neurobiology found that Antrodia cinnamomea, a medicinal fungus extract, worked best when carried on citrate-stabilized silver nanoparticles in cell and rat models of Parkinson’s-like dopamine injury. Key Findings 6-OHDA create…
Read article
TL;DR: A 2026 medRxiv preprint found that alpha-synuclein seed-positive Parkinson’s patients had slower ON-medication motor progression, measured while usual Parkinson’s medication was active, and more sustained levodopa responsiveness than matched seed-negati…
Read article
Alpha-Synuclein Testing Could Clarify Dementia Diagnosis TL;DR: In 398 memory-clinic patients, alpha-synuclein seed testing identified Lewy body dementia with 95% sensitivity and revealed hidden synuclein positivity in 15.8% of Alzheimer’s disease cases. Key F…
Read article
Chlorpyrifos Linked to 2.5x Higher Parkinson’s Risk TL;DR: A pesticide sprayed on US crops decades ago more than doubles your risk of Parkinson’s disease, and new research shows exactly how it damages dopamine neurons. You probably never heard of chlorpyrifos,…
Read article